A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)

A protein called Agrin naturally produced in the skin could soon be the active ingredient in a treatment to boost skin repair in non-healing wounds.

Multidisciplinary efforts across A*STAR are paving the way toward Singapore’s precision medicine vision.

To meet Singapore’s goal of sustainable food production, the trio behind the A*STAR spinoff Meatiply reveals their journey in building the company and developing alternative proteins.

New gastric cancer insights come to light with the help of powerful single-cell technologies.

The A*STAR winners of the 2021 President’s Science and Technology Awards and Young Scientist Award are living proof of the importance of mentorship in creating science that gives back to the community.

The National Research Foundation Singapore will support the research ambition of four A*STAR researchers through two key programmes—the NRF Fellowship and the NRF Investigatorship.

A molecular tagging tool developed in Singapore identifies novel protein interactions on the surface of cancer cells.

A breakthrough discovery describes key molecular players involved in insulin secretion, paving the way for a new class of gene therapies targeting type 2 diabetes.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.

Ushering in an era of targeted precision medicine, scientists across A*STAR are propelling the research, commercialisation and implementation of RNA-based therapeutics.

Delving deep into the fundamentals of development and the frontiers of disease therapeutics, Mei Sheng Lau unravels the roles chromatin plays in gene regulation.

A*STAR researchers challenge existing theories around intestinal stem cell biology using a newly developed animal model of intestinal regeneration.